Want to see XRN full AI Analyst Report?
Top Page
Chiron Real Estate ate
(NYSE:XRN)
Select Model
Select Model
Rating:63Neutral
Price Target:
$38.00
▲(7.04% Upside)
Action:Reiterated
Date:08/11/26
XRN’s score is driven primarily by mixed financial performance: strong current cash flow and improved leverage are tempered by a sharp TTM revenue collapse and historical volatility. Valuation is a notable positive with a low P/E and high dividend yield. Technical signals are currently neutral-to-weak, while the latest earnings call was moderately positive due to tangible progress on the senior housing pivot, though leverage and execution timing remain key risks.
Positive Factors
Cash generation
Sustained positive operating cash flow and strong trailing free cash flow provide a durable funding source to cover distributions, redeploy capital from sales, and support the senior-housing pivot. Consistent cash conversion underpins capital allocation flexibility and reduces near-term refinancing pressure.
Negative Factors
Revenue collapse
A near-total TTM revenue decline signals structural disruption to the top line that may not reverse quickly. Durable earnings and FFO depend on replacing lost outpatient revenues with stabilized seniors cash flow; prolonged revenue weakness strains predictability and growth planning.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Sustained positive operating cash flow and strong trailing free cash flow provide a durable funding source to cover distributions, redeploy capital from sales, and support the senior-housing pivot. Consistent cash conversion underpins capital allocation flexibility and reduces near-term refinancing pressure.
Read all positive factors
Chiron Real Estate ate Key Performance Indicators (KPIs)
Any
Revenue by Segment
Breaks revenue into the company’s business lines or property types, showing which segments drive cash flow, where growth is concentrated, and where the REIT may face risk from tenant mix, occupancy shifts, or changes in reimbursement or lease terms.
Breaks revenue into the company’s business lines or property types, showing which segments drive cash flow, where growth is concentrated, and where the REIT may face risk from tenant mix, occupancy shifts, or changes in reimbursement or lease terms.
Data provided by:
The Fly
The FlyChiron Real Estate ate (XRN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$533.69M
Dividend Yield5.38%
Average Volume (3M)92.86K
Price to Earnings (P/E)9.4
Beta (1Y)0.56
Revenue Growth4.16%
EPS Growth1006.24%
CountryUS
Employees30
SectorReal Estate
Sector Strength53
IndustryREIT - Healthcare Facilities
Share Statistics
EPS (TTM)3.72
Shares Outstanding13,237,830
10 Day Avg. Volume74,138
30 Day Avg. Volume92,855
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.92
Price to Sales (P/S)2.90
P/FCF Ratio-57.89
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$41.50Price Target Upside16.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)1.31
Revenue Forecast (FY)$148.93M
Chiron Real Estate ate Business Overview & Revenue Model
Company Description
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants w...
Chiron Real Estate ate Earnings Call Summary
Earnings Call Date:Aug 05, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 10, 2026
Earnings Call Sentiment Positive
The call conveyed a constructive strategic pivot toward senior housing with concrete execution: leadership additions, sizable asset sales and acquisitions, equity issuance, improved liquidity and modest improvement in leverage. At the same time, operating growth is modest, net debt/EBITDAre remains elevated, short-term G&A will rise due to hiring, and there is uncertainty and timing risk around fully monetizing outpatient medical assets and achieving market revaluation. Overall, the company demonstrated meaningful progress and tactical wins but still faces execution and valuation headwinds during the transition.Positive Updates
FFO and Core FFO
NAREIT defined FFO per share/unit of $0.88 and core FFO of $1.04 for Q2 2026, indicating positive earnings generation on a per-share basis.
Negative Updates
Modest Same-Store Cash NOI Growth
Same-store cash NOI growth was modest at 0.8% YoY (normalized 1.7%), showing only limited near-term organic operating growth after excluding a prior-year one-time item.
Read all updates
Q2-2026 Updates
Positive
Negative
FFO and Core FFO
NAREIT defined FFO per share/unit of $0.88 and core FFO of $1.04 for Q2 2026, indicating positive earnings generation on a per-share basis.
Read all positive updates
Company Guidance
Management's guidance emphasized disciplined capital allocation and portfolio repositioning with specific financials: Q2 NAREIT FFO per share/unit $0.88 and core FFO $1.04; same‑store cash NOI +0.8% year‑over‑year (or +1.7% on a normalized basis excluding a prior‑year nonrecurring recovery) and same‑store NOI +1.7% normalized; net debt to adjusted EBITDAre 6.0x (down from 6.6x in Q1), leverage just under 40% with no maturities until 2028 and ~$259M of unused credit capacity; they issued $100M of Series C convertible perpetual preferred, closed a $100M May investment, sold seven IRFs for ~$217M at a 7.3% exit cap rate (retaining a small equity stake), are under contract to sell Beaumont for $49M at a 5.9% cap rate, and intend to redeploy proceeds into seniors assets (they cited $421M of seniors investments this quarter plus a $15M land parcel and $5M of mezz loans representing ~33 bps of the portfolio); cash G&A this quarter was $3.8M and management expects a short‑term increase in G&A as new hires ramp but believes costs will align with portfolio size as the transition progresses.Chiron Real Estate ate Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
58
Neutral
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.76M | 161.03M | 138.41M | 140.93M | 137.17M | 115.80M |
| Gross Profit | 608.00K | 10.32M | 109.16M | 112.85M | 111.98M | 100.32M |
| EBITDA | 158.71M | 96.73M | 91.47M | 111.64M | 102.89M | 85.35M |
| Net Income | 57.95M | -5.84M | 6.63M | 20.61M | 19.14M | 17.62M |
Balance Sheet | ||||||
| Total Assets | 1.37B | 1.24B | 1.26B | 1.27B | 1.39B | 1.26B |
| Cash, Cash Equivalents and Short-Term Investments | 10.66M | 12.45M | 6.82M | 1.28M | 4.02M | 7.21M |
| Total Debt | 636.93M | 663.74M | 653.59M | 624.19M | 704.65M | 579.86M |
| Total Liabilities | 687.71M | 712.40M | 700.57M | 661.89M | 744.20M | 625.91M |
| Stockholders Equity | 656.95M | 509.77M | 534.13M | 583.58M | 632.98M | 622.78M |
Cash Flow | ||||||
| Free Cash Flow | -187.64M | -8.08M | -25.07M | 58.39M | -79.66M | -132.69M |
| Operating Cash Flow | 75.11M | 73.61M | 70.05M | 68.44M | 76.54M | 68.97M |
| Investing Cash Flow | -75.67M | -60.40M | -45.94M | 67.62M | -137.25M | -194.66M |
| Financing Cash Flow | 4.26M | -10.26M | -21.89M | -143.79M | 62.41M | 127.70M |
Chiron Real Estate ate Technical Analysis
Positive
35.50
Price Trends
36.49
Positive
35.66
Positive
34.39
Positive
Market Momentum
0.25
Negative
52.42
Neutral
56.69
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XRN, the sentiment is Positive. The current price of 35.5 is below the 20-day moving average (MA) of 36.27, below the 50-day MA of 36.49, and above the 200-day MA of 34.39, indicating a bullish trend. The MACD of 0.25 indicates Negative momentum. The RSI at 52.42 is Neutral, neither overbought nor oversold. The STOCH value of 56.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XRN.
Chiron Real Estate ate Risk Analysis
Chiron Real Estate ate disclosed 63 risk factors in its most recent earnings report. Chiron Real Estate ate reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Chiron Real Estate ate Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $762.19M | 21.28 | 72.36% | 4.55% | ― | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | $428.37M | 22.27 | 4.96% | 10.14% | 5.66% | ― | |
63 Neutral | $533.69M | 9.42 | 10.77% | 10.01% | 4.16% | 1006.24% | |
57 Neutral | $576.24M | 29.61 | 12.79% | 6.80% | 0.75% | 7.29% | |
51 Neutral | $1.85B | -6.90 | -16.22% | 0.43% | -1.49% | 7.49% |
* Real Estate Sector Average
XRN
Chiron Real Estate ate
36.82
2.16
6.24%
DHC
Diversified Healthcare Trust
7.65
3.87
102.11%
CHCT
Community Healthcare
14.95
1.16
8.45%
UHT
Universal Health Realty Income
41.46
3.80
10.08%
STRW
Strawberry Fields REIT Inc
13.62
2.52
22.75%
Chiron Real Estate ate Corporate Events
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Chiron Real Estate posts Q2 profit, pivots to seniors housing
Positive
Aug 5, 2026
On August 5, 2026, Chiron Real Estate reported second-quarter 2026 results showing a sharp turnaround to net income of $63.3 million, or $4.78 per diluted share, versus a small loss a year earlier, even as FFO and Core FFO per share declined. Same...
Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
Chiron Real Estate Names Matthew Whitlock Chief Investment Officer
Positive
Aug 3, 2026
Effective August 3, 2026, Chiron Real Estate Inc. appointed 62-year-old Matthew Whitlock as Chief Investment Officer of both the company and Inter-American Management LLC, bringing extensive senior housing investment experience from Berkshire Resi...
Business Operations and StrategyFinancial Disclosures
Chiron Real Estate updates strategy toward senior housing
Positive
Jul 6, 2026
On July 6, 2026, Chiron Real Estate Inc. updated its investor presentation, outlining a strategic portfolio repositioning toward senior housing operating properties expected to deliver higher returns on invested capital. The company emphasized tha...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsRegulatory Filings and Compliance
Chiron Real Estate completes major hospital portfolio sale
Positive
Jul 2, 2026
On June 29, 2026, Chiron Real Estate Inc. completed the $217 million sale of a portfolio of seven inpatient rehabilitation hospital properties in Pennsylvania, Arizona, Texas, Nevada and Oklahoma to a group of Delaware LLC buyers affiliated with C...
Business Operations and StrategyM&A TransactionsPrivate Placements and FinancingRegulatory Filings and Compliance
Chiron Real Estate Expands Portfolio with Landing Alexandria Acquisition
Positive
Jun 2, 2026
On May 28, 2026, Chiron Real Estate Inc., as sole member of the general partner of Chiron Real Estate LP, amended the partnership agreement to create Series C Convertible Preferred Units mirroring its Series C Convertible Preferred Stock, and cont...
Business Operations and StrategyExecutive/Board ChangesDividendsShareholder Meetings
Chiron Real Estate Expands Board, Strengthens Governance Oversight
Positive
May 20, 2026
On May 20, 2026, Chiron Real Estate Inc. expanded its board from six to seven members and appointed veteran real estate investor Charles Fitzgerald as an independent director, with roles on the Compensation and Nominating and Corporate Governance ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.